Neurological Disorders tests in Dubai & UAE

Compare available Neurological Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Disorders test prices

Showing 1–14 of 14 matching tests.

Neurological Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4412 ADGRV1 Gene Febrile Seizures, Familial, Type 4 Genetic Test This test identifies pathogenic mutations in the ADGRV1 gene associated with familial febrile seizures type 4.	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the ADGRV1 gene"] Parameters [] Preparation ["No fasting required", "Continue prescribed medications unless advised otherwise by a doctor"] Indications ["Diagnosis of familial febrile seizures type 4", "Risk assessment for recurrence in family members", "Guiding clinical management"] Measurement technique Confirm with laboratory Codes LOINC: 94086-1 ICD-10: R56.0 Clinical summary This test identifies pathogenic mutations in the ADGRV1 gene associated with familial febrile seizures type 4.
TEST-4800 ARID1B Gene Sequencing (NGS) Test This diagnostic test evaluates the ARID1B gene for pathogenic variants associated with Autosomal Dominant Intellectual Disability Type 12 and Coffin-Siris Syndrome 1.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3 to 4 Weeks (expedited 2-week option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARID1B gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations (CNV)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9%"}, {"name": "Mean Read Depth", "reference_range": "≥100x"}] Preparation ["Inform laboratory of all current medications, including anti-epileptics, neuroleptics, and melatonin supplements.", "No fasting required.", "Mandatory pre-test genetic counselling session."] Indications ["Suspected Autosomal Dominant Intellectual Disability Type 12", "Suspected Coffin-Siris Syndrome 1", "Family cascade screening for ARID1B variants"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.1, F78.A Clinical summary This diagnostic test evaluates the ARID1B gene for pathogenic variants associated with Autosomal Dominant Intellectual Disability Type 12 and Coffin-Siris Syndrome 1.
TEST-3671 Ataxia Genetic Test) This test identifies genetic mutations associated with various forms of hereditary ataxia.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in ataxia-related genes", "Copy Number Variations (CNVs) in ataxia-related genes"] Parameters [] Preparation ["Fasting is not required", "Provide a list of current medications and supplements", "No supplements or drugs need to be discontinued"] Indications ["Diagnosis of suspected hereditary ataxia", "Predictive testing for individuals with family history", "Carrier screening", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 92195-6 ICD-10: G11.9, G11.0, G11.1, G11.2, G11.3, G11.4, G11.8 Clinical summary This test identifies genetic mutations associated with various forms of hereditary ataxia.
TEST-3771 FIG4 Gene Amyotrophic Lateral Sclerosis Type 11 Genetic Test This genetic test identifies pathogenic variants in the FIG4 gene, which are linked to Autosomal Dominant Amyotrophic Lateral Sclerosis type 11.	Peripheral Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FIG4 gene"] Parameters [] Preparation ["Mandatory genetic counselling session before sample collection"] Indications ["Suspected Autosomal Dominant Amyotrophic Lateral Sclerosis type 11", "Family history of ALS11"] Measurement technique Confirm with laboratory Codes LOINC: 93942-8 ICD-10: G12.21 Clinical summary This genetic test identifies pathogenic variants in the FIG4 gene, which are linked to Autosomal Dominant Amyotrophic Lateral Sclerosis type 11.
TEST-5953 FKTN Gene Walker-Warburg Syndrome Genetic Test This test evaluates the FKTN gene for pathogenic variants associated with Walker-Warburg syndrome using Next-Generation Sequencing.	Peripheral whole blood (3–5 mL EDTA)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FKTN gene", "Copy Number Variations (CNV) in the FKTN gene"] Parameters [] Preparation ["No special dietary preparation required"] Indications ["Infants and children with suspected Walker-Warburg syndrome", "Carrier screening for at-risk couples with a family history"] Measurement technique Confirm with laboratory Codes LOINC: 94219-4 ICD-10: Q04.3 Clinical summary This test evaluates the FKTN gene for pathogenic variants associated with Walker-Warburg syndrome using Next-Generation Sequencing.
TEST-5383 HCRT Gene Narcolepsy DNA Test (NGS) This test identifies mutations in the HCRT gene, which are a known cause of narcolepsy type 1.	Peripheral whole blood	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the HCRT gene coding region"] Parameters [] Preparation ["No specific fasting required", "Avoid strenuous activity before sample collection"] Indications ["Suspected narcolepsy type 1 (with cataplexy)", "Family history of narcolepsy", "Differential diagnosis of excessive daytime sleepiness"] Measurement technique Confirm with laboratory Codes LOINC: 81432-9 ICD-10: G47.411 Clinical summary This test identifies mutations in the HCRT gene, which are a known cause of narcolepsy type 1.
TEST-3818 NLGN3 Gene Asperger Syndrome Susceptibility X-Linked Type 2 Genetic Test This genetic test evaluates the NLGN3 gene for variants associated with X-linked Asperger syndrome susceptibility.	Peripheral Whole Blood (EDTA) or Dry Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NLGN3 gene", "SNVs", "Indels", "CNVs"] Parameters [] Preparation [] Indications ["Individuals with a family history of Asperger syndrome", "Individuals with unexplained social-communication delays", "Following genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 92872-6 ICD-10: Z15.89 Clinical summary This genetic test evaluates the NLGN3 gene for variants associated with X-linked Asperger syndrome susceptibility.
TEST-3796 OPTN Gene ALS Type 12 Genetic Test This genetic test evaluates the OPTN gene for pathogenic variants associated with amyotrophic lateral sclerosis type 12 (ALS12).	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the OPTN gene", "Presence of mutations linked to ALS12"] Parameters [] Preparation ["No specific fasting required", "Inform team if blood transfusion received in last 90 days"] Indications ["Diagnosis of suspected ALS type 12", "Family risk assessment for ALS12"] Measurement technique Confirm with laboratory Codes LOINC: 94646-4 ICD-10: G12.2 Clinical summary This genetic test evaluates the OPTN gene for pathogenic variants associated with amyotrophic lateral sclerosis type 12 (ALS12).
TEST-5030 PAK3 Gene Mental Retardation, X-linked Type 30 Genetic Test This genetic test identifies pathogenic variants in the PAK3 gene associated with X-linked intellectual disability type 30.	Peripheral whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PAK3 gene", "Single-nucleotide variants", "Copy-number variants"] Parameters [] Preparation ["No fasting required", "No special preparation unless instructed by physician"] Indications ["Suspected X-linked intellectual disability type 30", "Family history of PAK3-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 78027-6 ICD-10: F78.9 Clinical summary This genetic test identifies pathogenic variants in the PAK3 gene associated with X-linked intellectual disability type 30.
TEST-4227 PDE10A Gene Dyskinesia (Limb and Orofacial, Infantile-Onset) Genetic Test This genetic test identifies pathogenic variants in the PDE10A gene associated with severe infantile-onset limb and orofacial dyskinesia.	Peripheral whole blood, extracted DNA, or FTA card blood spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PDE10A gene"] Parameters [] Preparation ["Provide detailed clinical history", "Genetic counselling recommended"] Indications ["Suspected PDE10A-related dyskinesia", "Family history of infantile-onset dyskinesia"] Measurement technique Confirm with laboratory Codes LOINC: 48808-2 ICD-10: G25.8 Clinical summary This genetic test identifies pathogenic variants in the PDE10A gene associated with severe infantile-onset limb and orofacial dyskinesia.
TEST-4031 PRKCH Gene Cerebral Infarction Susceptibility Genetic Test This genetic test evaluates for pathogenic variants in the PRKCH gene associated with an increased risk of cerebral infarction, especially lacunar strokes.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRKCH gene", "Genetic susceptibility to cerebral infarction"] Parameters [] Preparation ["No fasting required"] Indications ["Individuals with a strong family history of early-onset lacunar stroke", "Individuals with multiple unexplained cerebrovascular events"] Measurement technique Confirm with laboratory Codes LOINC: 21794-4 ICD-10: Z15.89 Clinical summary This genetic test evaluates for pathogenic variants in the PRKCH gene associated with an increased risk of cerebral infarction, especially lacunar strokes.
TEST-4521 PRNP Gene Huntington Disease-Like Type 1 Genetic Test This test evaluates the PRNP gene for pathogenic variants associated with Huntington disease-like type 1.	Peripheral Blood (Whole Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PRNP gene sequence", "Pathogenic variants", "Repeat expansions"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected Huntington disease-like type 1", "Family history of prion disorders", "Differential diagnosis of Huntington disease"] Measurement technique Confirm with laboratory Codes LOINC: 31208-4 ICD-10: Z13.81 Clinical summary This test evaluates the PRNP gene for pathogenic variants associated with Huntington disease-like type 1.
TEST-5702 VAMP1 Gene Spastic Ataxia Type 1, Autosomal Dominant Genetic Test This test identifies pathogenic variants within the VAMP1 gene associated with Autosomal Dominant Spastic Ataxia Type 1.	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VAMP1 gene sequence", "Single nucleotide variants (SNVs)", "Insertions", "Deletions", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of Autosomal Dominant Spastic Ataxia Type 1", "Family history of Spastic Ataxia Type 1", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants within the VAMP1 gene associated with Autosomal Dominant Spastic Ataxia Type 1.
TEST-5492 VRK1 Gene Pontocerebellar Hypoplasia Type 1A Genetic Test This genetic test evaluates the VRK1 gene for pathogenic variants associated with Pontocerebellar Hypoplasia Type 1A.	Whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VRK1 gene coding region", "Pathogenic variants in VRK1"] Parameters [] Preparation [] Indications ["Infants presenting with microcephaly, cerebellar hypoplasia, and severe psychomotor delay"] Measurement technique Confirm with laboratory Codes LOINC: 95411-6 ICD-10: Q04.8 Clinical summary This genetic test evaluates the VRK1 gene for pathogenic variants associated with Pontocerebellar Hypoplasia Type 1A.

Category overview

Neurological Disorders: overview

Navigating a family history of progressive, debilitating brain or nerve conditions warrants proactive, empowering insights to break the cycle of diagnostic uncertainty and protect your future health. Integrated into our comprehensive Genetics department, testing for inherited Neurological Disorders evaluates your DNA for a vast spectrum of familial mutations passed down through generations. Utilizing state-of-the-art sequencing technology, this expansive molecular profiling helps identify hidden molecular risks long before symptoms escalate, safely guiding your healthcare provider in tailoring highly personalized preventative care, customized medical therapies, and proactive neurological monitoring. Recognized for preventative diagnostic excellence among the best diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, unparalleled diagnostic accuracy, and remarkably fast reporting. Safeguard your family’s neurological future—book your neurological disorders testing in UAE, arrange a secure home sample collection, or consult our expert medical genetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.